The CADM diagnosis was significantly associated with anti-MDA5 positive status (8 of 14 MDA5-positive patients versus 7 of 103 MDA5-negative (P < 0.05; OR: 18.3, 95% CI 4.9–67.6)). This evidence concerns the gene IFIH1 and clinically amyopathic dermatomyositis.